[DOI] [PubMed] [Google Scholar] 142
Before you consider the switch, check in on your current status: what dose youre on, how well youre tolerating it, what your body weight and metabolic markers (blood sugar, HbA1c, lipids) are doing, and whether youre experiencing side-effects or plateauing
MEDVi is a doctor-led, telehealth weight loss program created for adults in the USA who want a proven, medical approach to fat loss without the stress of traditional dieting
Originally developed for treatment of type 2 diabetes in 2004, and later approved for weight loss in 2014, GLP-1s have demonstrated clinically meaningful reductions in A1c as well as unprecedented weight loss, with patients losing up to 20% of t heir body weight. There has been rapid adoption and a surge in demand for incretin-based therapies